M. catarrhalis (previously Branhamella catarrhalis) - associated with respiratory tract infection, endocarditis, bacteraemia - reported susceptible to cefuroxime
Other spp. associated with infection - M. atlantae, M. lacunata, M. nonliquefaciens, M. osloensis, M. phenylpyruvica - associated with - conjunctivitis, wound infection, endocarditis, abscesses, osteomyelitis - reported susceptibilities, penicillin - penicillin-resistance reported
For M. urethralis - see Oligella urethralis
References - Silverfarb, P.M., Lawe, J.E. (1968). Endocarditis due to Moraxella liquefaciens. Arch. intern. Med. 122, 512-513. - Ebright, J.R., Lentino, J.R., Juni, E. (1982). Endophthalmitis cused by Moraxella nonliquefaciens. Am. J. clin. Pathol. 77, 362-363. - Bøvre, K., Henriksen, S.D. (1967). A new Moraxella speceies, Moraxella osloensis, and a revised description of Moraxella nonliquefaciens. Int. J. syst. Bacteriol. 17, 127-135. - Bøvre, K., Fuglesang, J.E., Hagen, N. (1976). Moraxella atlantae sp. nov. and its distinction from Moraxella phenylpyruvica. Int. J. syst. Bacteriol. 26, 511-521. - Percival, A., Coskill, J.E., Rowlands, J. et al. (1977). Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis. Lancet. 2, 1175.
